Bio Green Med Solution (BGMS) Cash from Operations (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Cash from Operations of 278000.0 for Q1 2026, up 91.44% year-over-year from 145216.54 in Q1 2025, and down 742.42% quarter-over-quarter from 33000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash from Operations (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Cash from Operations for 17 consecutive years, with 278000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 91.44% year-over-year to 278000.0; the TTM figure through Mar 2026 stood at 1801000.0 (up 83.25% YoY), while the FY2025 annual figure was 4770000.0, up 40.3% from the prior year.
- Cash from Operations retreated to 278000.0 in Q1 2026 per BGMS's latest filing, from 33000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 33000.0 in Q4 2025 and bottomed at 6968000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 2939823.53 across 5 years, with a median of 3067000.0 in 2024.
- On a YoY basis, Cash from Operations climbed as much as 97.57% in 2025 and fell as far as 572.26% in 2025.
- Bio Green Med Solution's Cash from Operations stood at 5169000.0 in 2022, then advanced by 24.36% to 3910000.0 in 2023, then jumped by 65.32% to 1356000.0 in 2024, then surged by 97.57% to 33000.0 in 2025, then plunged by 742.42% to 278000.0 in 2026.
- Business Quant data shows BGMS's Cash from Operations at 278000.0 in Q1 2026, 33000.0 in Q4 2025, and 434000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.60 Bn | 133.75 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.38 Bn | 78.38 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.83 Bn | 59.64 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.69 Bn | 52.56 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.46 Bn | 44.46 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.31 Bn | 35.21 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.12 Bn | 27.28 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.40 Bn | 26.23 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Bio Green Med Solution | 4.95 Mn | 1.16 Mn | 79,000.00 | -352,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -352,000.00 |
| Mar 31, 2026 | -278,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -434,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | -1.36 Mn |
| Sep 30, 2024 | -3.07 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | -483,000.00 |
| Dec 31, 2023 | -3.91 Mn |
| Sep 30, 2023 | -4.04 Mn |
| Jun 30, 2023 | -1.31 Mn |
| Mar 31, 2023 | -6.86 Mn |
| Dec 31, 2022 | -5.17 Mn |
| Sep 30, 2022 | -6.97 Mn |
| Jun 30, 2022 | -1.92 Mn |
| Mar 31, 2022 | -6.78 Mn |
| Dec 31, 2021 | -4.55 Mn |
| Sep 30, 2021 | -6.21 Mn |